fbpx

Day

juni 26, 2015
Veloxis Pharmaceuticals A/S (OMX: VELO) today announced top-line results of the ASTCOFF study, A STeady-state Pharmacokinetic COmparison Of all FK-506 Formulations, demonstrating that once-daily Envarsus® XR (tacrolimus extended-release tablets), an investigational new drug under FDA review for the prevention of organ rejection in adult kidney transplant patients, achieved differentiated pharmacokinetics (PK) when compared to twice-daily...

Nyheder

Vægt
Fedme sidder i hjernen
24. september 2020
442 vikingeskeletter fik en tur i DNA-maskinen – nu revideres historien om vikingekulturen
16. september 2020
Håb om at kunne kurere type 2 diabetes med indsprøjtning i hjernen
7. september 2020

Lundbeckfonden

Lundbeckfonden Ventures

Lundbeckfonden Emerge